This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Cross Country Healthcare (CCRN) Crossed Above the 50-Day Moving Average: What That Means for Investors
by Zacks Equity Research
Should investors be excited or worried when a stock crosses above the 50-Day simple moving average?
Cross Country Healthcare (CCRN) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Cross Country (CCRN) delivered earnings and revenue surprises of 17.50% and 8.41%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Cross Country Healthcare (CCRN) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Cross Country (CCRN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Reasons to Retain Envestnet (ENV) Stock in Your Portfolio
by Zacks Equity Research
Envestnet's (ENV) business model ensures solid asset-based and subscription-based recurring revenue generation capacity.
Reasons to Retain DocuSign (DOCU) Stock in Your Portfolio
by Zacks Equity Research
DocuSign's (DOCU) top line is significantly benefiting from continued customer demand for eSignature.
6 Reasons to Add Trane Technologies (TT) to Your Portfolio
by Zacks Equity Research
Trane Technologies (TT) remains focused on sustained improvement in revenues, earnings and cash flow.
Booz Allen Hamilton (BAH) Signs Deal to Invest in Latent AI
by Zacks Equity Research
Booz Allen's (BAH) investment in Latent AI is aimed at helping its clients effectively implement machine learning models.
Reasons to Retain Charles River (CRAI) in Your Portfolio
by Zacks Equity Research
Charles River (CRAI) has a diversified business with service offerings across areas of functional expertise, client base and geographical regions.
Reasons to Hold Insperity (NSP) Stock in Your Portfolio
by Zacks Equity Research
Insperity (NSP) looks strong on the back of a growing PEO industry which is currently being driven by growth of small- and medium-sized businesses.
Reasons to Retain FTI Consulting (FCN) in Your Portfolio
by Zacks Equity Research
FTI Consulting (FCN) has a broad range of practices and services, well-diversified revenue streams and strong client relationships. Its debt burden remains a concern.
Reasons to Hold Green Dot (GDOT) Stock in Your Portfolio
by Zacks Equity Research
Green Dot (GDOT) is expanding its addressable market with the help of its banking-as-a-service (BaaS) account programs.
Here's Why You Should Hold WEX Stock in Your Portfolio Now
by Zacks Equity Research
Strategic acquisitions and revenue-generation efforts are aiding WEX stock. However, high debt is worrisome.
Here's Why You Should Retain IQVIA Holdings (IQV) Stock For Now
by Zacks Equity Research
IQVIA's (IQV) unique ability to standardize, organize and integrate information through applying sophisticated analytics and global technology infrastructure helps it build a strong client base.
Here's Why You Should Retain Clean Harbors (CLH) Stock Now
by Zacks Equity Research
Shareholder-friendly measures aid Clean Harbors (CLH) stock. However, high debt is a concern.
Revenue Growth Aids Paychex (PAYX) Amid High Talent Cost
by Zacks Equity Research
Paychex's (PAYX) solid business model, diverse products and services, and strategic acquisitions boost top-line growth. However, rising talent cost is a concern.
Here's Why You Should Retain Equifax (EFX) in Your Portfolio
by Zacks Equity Research
Equifax's (EFX) top line is showing a decent growth rate over the past few years. A debt-laden balance sheet remains a concern.
Here's Why You Should Retain ADP Stock in Your Portfolio
by Zacks Equity Research
ADP's three-tier business strategy is helping it to maintain and grow its strong position as an HCM technology and services provider.
Envestnet Yodlee (ENV) Collaborates With Amazon Web Services
by Zacks Equity Research
The move seems to be part of Envestnet s (ENV) efforts to increase the availability of its data analytics offerings globally.
IQVIA (IQV) Announces Launch of Clinical Data Analytics Suite
by Zacks Equity Research
IQVIA's (IQV) new platform brings benefits such as real-time data management, reduced data-harmonization efforts, reduced time of KPI deployment and improved decision making.
Green Dot (GDOT)-Issued Walmart MoneyCard Gets DDA Features
by Zacks Equity Research
The move provides Walmart MoneyCard's customers access to Green Dot's (GDOT) digital banking platform in a way similar to traditional banking accounts.
Accenture (ACN) to Snap Up Paris-Based Exton Consulting
by Zacks Equity Research
The buyout will increase Accenture's (ACN) ability to manage transformational projects pertaining to strategy, design, technology and operations.
Cross Country Healthcare's (CCRN) Shares March Higher, Can It Continue?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Cross Country Healthcare, Inc. (CCRN).
Here's Why Investors Should Buy ManpowerGroup (MAN) Stock Now
by Zacks Equity Research
Shareholder-friendly movements as well as solid cash balance drive ManpowerGroup (MAN) stock.
Envestnet Yodlee (ENV) Announces Collaboration With Snowflake
by Zacks Equity Research
The move seems to be part of Envestnet's (ENV) efforts to increase availability of its data analytics offerings.
6 Reasons Why You Should Bet on Trane Technologies (TT) Stock
by Zacks Equity Research
Trane Technologies (TT) remains focused on improving the quality of its products and services, and operating efficiencies, so as to achieve sustained improvement in earnings and cash flow.